EXBAQ LLC
Bethesda, United States · Founded 2020 · $294K raised
- Headquarters
- Bethesda, Maryland
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Total Funding
- $294K
- Last Round
- $294K GrantJan 2021
- Rounds
- 2
About
Exbaq is an early-stage biotech company and exclusive licensee of a USC-developed experimental vaccine targeting antibiotic-resistant superbugs that cause hospital-acquired infections. The vaccine has demonstrated protection against multiple highly resistant bacterial pathogens within 24 hours, as published in Science Translational Medicine.
Summary
EXBAQ LLC is a Biotech company based in Bethesda, United States, founded in 2020. It has raised $294K in total across 2 rounds, most recently a $294K Grant round in Jan 2021. Investors include National Institute of Allergy and Infectious Diseases.
Funding History
Jan 2021
Sign up to see all 2 rounds
Grant — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/exbaq-llc"><img src="https://indexed.vc/api/badge/company/exbaq-llc" alt="EXBAQ LLC on Indexed.vc" width="260" height="76" /></a>